BiotechTube
Home/Tavanta Therapeutics/Lynne Powell
LP

Lynne Powell

Chief Executive Officer

Tavanta Therapeutics

Therapeutic Areas

OncologyColorectal CancerUro-oncology

Tavanta Therapeutics Pipeline

DrugIndicationPhase
Undisclosed Colorectal Program(s)Colorectal CancerPhase 2
Undisclosed Uro-oncology Program(s)Uro-oncology (e.g., bladder, kidney, prostate cancers)Phase 2

Leadership Team at Tavanta Therapeutics

DA
Dr. Andreas Maetzel
Chief Medical Officer
DB
Darren Brayton
Vice President, Technical Operations
DE
Dr. Elizabeth Manning Duus
Vice President, Clinical Development
View full Tavanta Therapeutics profile